Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602-Reference-Cited by-同舟云学术

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602

Published:2016-09 Issue: Volume:64 Page:22-31
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Onda Takashi,Satoh Toyomi,Saito Toshiaki,Kasamatsu Takahiro,Nakanishi Toru,Nakamura Kenichi,Wakabayashi Masashi,Takehara Kazuhiro^ORCID,Saito Motoaki,Ushijima Kimio,Kobayashi Hiroaki,Kawana Kei,Yokota Harushige,Takano Masashi,Takeshima Nobuhiro,Watanabe Yoh,Yaegashi Nobuo,Konishi Ikuo,Kamura Toshiharu,Yoshikawa Hiroyuki

Funder

Health Sciences Research Grants for the Third-Term Comprehensive Control Research for Cancer

Health Sciences Research Grants for Clinical Cancer Research

Ministry of Health, Labor and Welfare, Japan

National Cancer Center Research and Development Funds

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference14 articles.

1. Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer;Jacob;Gynecol Oncol,1991

2. Neoadjuvant chemotherapy in advanced ovarian cancer;Onnis;Eur J Gynaecol Oncol,1996